Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Gastrointestinal 2 CNS 2 Breast 2 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Dermatologic 1

Conditions

Pleural Effusion, Malignant 1

Interventions

Carboplatin 1152 Cisplatin 876 Pemetrexed 834 pembrolizumab 608 Paclitaxel 598 Docetaxel 535 Gemcitabine 424 Radiotherapy 377 Erlotinib Hydrochloride 367 Nivolumab 322 Bevacizumab 322 Etoposide 295 durvalumab 254 Drug Therapy 233 osimertinib 218 atezolizumab 208 Radiosurgery 190 Gefitinib 177 Vinorelbine 145 130-nm albumin-bound paclitaxel 124 Magnetic Resonance Spectroscopy 121 Ipilimumab 118 Cetuximab 113 anlotinib 104 tislelizumab 103 Topotecan 101 Cyclophosphamide 101 Taxes 99 Irinotecan 95 Albumin-Bound Paclitaxel 92

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Verteporfin × Thoracic × Clear all

NCT02702700 2019-03-20

PDT-lipo

Centre Hospitalier Universitaire Vaudois

Phase 1 Terminated

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡